IGPH — IGEA Pharma NV Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣0.51m
- CH₣0.90m
Annual cashflow statement for IGEA Pharma NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | Final | Final |
| Net Income/Starting Line | -1.21 | -1.7 | -0.999 | -1.26 | -11.8 |
| Depreciation | |||||
| Non-Cash Items | 0.003 | 0.149 | 0 | 0.458 | 10.3 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.031 | 0.142 | 0.125 | -0.285 | 1.08 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.17 | -1.28 | -0.791 | -1.09 | -0.401 |
| Capital Expenditures | 0 | -0.157 | 0 | — | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | 0.292 | -0.107 |
| Sale of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.157 | 0 | 0.292 | -0.107 |
| Financing Cash Flow Items | 2.76 | -0.006 | 0.487 | 0.702 | 0.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.01 | -0.055 | 0.49 | 0.632 | 0.514 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.81 | -1.52 | -0.274 | -0.071 | 0.013 |